The basic molecular mechanisms regulating prostate cancer (PCA) development and progression are very poorly understood. Different tumor suppressor genes are implicated in PCA. In particular, since the mutation rate of the p53 gene is also low, researchers have speculated that an infectious agent might play an important role in PCA. Polyomaviruses are candidates for this agent. We selected a patient with a diagnosis of PCA and underwent radical prostatectomy, to investigate the presence of polyomavirus BK (BKV) sequences (urine and neoplastic tissues) and the mutation pattern of p53 gene. The results obtained showed the presence of BKV DNA and of p53 gene mutations in exons 6, 8 and 9. We speculate that BKV might contribute to cellular transformation process, triggered possibly by p53 gene mutations.
Prostate cancer (PCA) is the second leading cause of cancer deaths in older men in the US (1). PCA is divided into hereditary and sporadic forms. Most prostate cancers are sporadic. The basic molecular mechanisms regulating the development and progression of PCA are still very poorly understood (2) (3) (4) . Recognition of the precursor lesions of PCA has become a primary focus in recent years, such as high-grade prostate intraepithelial neoplasm (HGPIN) (5) and atrophic epithelium in postatrophic hyperplasia (PAH) (6) (7) (8) . The tumor suppressor genes p53,Rb 1 and pRb2/p 130 have been implicated in PCA progression (9) (10) 29) and, since the mutation rate of the p53 gene in PCA is also low, researchers have speculated that an infectious agent might playa role in PCA (11). Polyomaviruses are candidates for this agent, although the etiological role of polyomaviruses in human tumors remains debated despite several reports demonstrating the presence and expression of viral sequences in neoplastic cells (12) (13) (14) (15) .
The human polyomavirus BK (BKY), first isolated from the urine of a renal transplant patient (16) , persistently infects almost 80-90% of the human population by early childhood (17) . The virus resides in the kidneys in a latent or persistent state, but can be reactivated upon immunosuppression of the host, and it is associated with hemorrhagic cystitis and polyomavirus nephropathy (18) . BKV oncogenically transforms primary human cells in culture when coexpressed with an activated ras oncogene (19) and is detected in some human tumors (reviewed in [12] [13] [14] [15] . The BKV genome is divided into regulatory, early and late regions (20) . The early proteins are the large tumor antigen (TAg) and the supporting small tumor antigen. TAg aids in the oncogenic transformation of cells through its ability to bind and inactivate the products of tumor suppressor genes , including p53 and the pRb family (15, 20) . TAg also regulates viral DNA replication and gene expression, and co-regulates activated and basal cellular transcription factors (21) . It was speculated that mutant genomes impaired for replication might integrate into the host genome and eventually lead to cancer, however the role ofBKV in human neoplasia is not clear (22) (23) .
Since 
bp
the human papillomavirus E6 and E7gene products in cervical carcinomas (24) .
We selected a patient with a clinically localized PCA and underwent radical prostatectomy, to investigate the presence of BKV sequences in urine and neoplastic prostate tissues using conventional and real time PCR. Moreover, a specific PCR was performed to screen the mutation pattern ofp53 gene in exons 5 to 9 that are the highly mutated in human cancer.
Case report
We selected a patient with a diagnosis of clinically localized adenocarcinoma of the prostate who underwent radical prostatectomy. A 67-year-old man was admitted to the Policlinico "Umberto I" in Rome, Italy, on April 2005 because he presented a history of prostatism (frequent urination especially at night; inability to urinate; pain during urination; blood in the urine). The digital rectal examination was performed and an induration of the prostate was found. Urine analysis revealed a great number of erythrocytes in the sample. PSA level was 12 mg/ml. Computerized tomography (TC) of the pelvis revealed no pathologically enlarged lymph nodes. A transrectal echography of the prostate with prostatic biopsy (7 fragments analysed) was performed. The histological analysis of biopsy fragments was performed by hematoxylin and eosin (HE) stained slides and revealed a high-grade prostatic intraepithelial neoplasia [Gleason 
rc« analysis
Samples of fresh adenocarcinoma prostate resections and urine were analysed. The fresh adenocarcinoma prostate resection and the urine specimens were incubated in lysis buffer and proteinase K (200 mg/m\). DNA extraction was performed by the QIAamp Tissue Kit (QIAGEN) according to the manufacturer's instructions. 0.1-1 ug of total purified DNA was used. DNA quality for PCR analysis was tested by PCR of the~-globin gene sequence as control. PCR analysis and PCR procedures were performed as published (25):~-globin-positive samples were amplified in GeneAmp PCR System 9600 (Perkin-Elmer). The PCR products were detected by ethidium bromide staining after electrophoretic migration through 2% agarose gel. DNA extracted from prostate samples were analysed by means of PCR using primers that amplified a 180 bp fragment corresponding to BKY early region (TAg) (26) and by means of quantitative PCR (Applied Biosystems 7300 Real-Time PCR System) with Q-BKY AmpliMIX and Q-BKY AmpliStandard (Applied Biosystems). DNA extracted from urine specimen was analysed by PCR using primers annealing to BKY non coding control region (NCCR) and amplified a 354 bp fragment (27) . p53 mutational analysis was carried out by SNPCapture™p53 Mutation Screening Kit (Panomics) according to the manufacturer s instructions. All the experiments were performed at least in triplicate.
RESULTS
A case report of a patient with prostate adenocarcinoma was examined in this study. The histological analysis of biopsy fragments was performed by HE stained slides and revealed a highgrade prostatic intraepithelial neoplasia. The tumour, according to Gleason's grading system, was classified as Gleason 9 (4+5). This histological evaluation of the tumor was confirmed after prostatectomy. The clinical TNM classification revealed a stage III cancer with a T3b lesion (pT3b pNO pMx). Our study was performed using qualitative and quantitative PCR with BKV specific primers to detect viral DNA and using a specific PCR assay in order to analyze the presence of p53 mutations from exons 5 to 9, the most target sites of p53 mutations in human neoplasia.
The results obtained showed that the prostate adenocarcinoma samples were positive for BKV TAg DNA in qualitative ( Fig. la) and quantitative PCR (75 copies/ug) ( Fig. Ib) and the urine sample was positive for BKV NCCR DNA (Fig. 2) . Moreover, in the prostate specimen the p53 gene mutation analysis of exons 5 to 9 revealed a mutation in exons 6, 8 and 9, whereas the others exons analysed showed a wild type genotype (Fig. 3) .
DISCUSSION
Prostate cancer is a common neoplasia affecting worldwide population. PCA is one of the leading diagnosed malignancies in men in Western countries and it has a complex molecular pathology. Several genes are involved in its pathogenesis, as well as environmental factors like diet and inflammation. In spite of the availability of biomarkers for PCA, the basic molecular mechanisms regulating its development and progression are still very poorly understood (2) (3) (4) . Among the several goals of cancer research, regulators of the apoptotic pathway, including p53, have been at the forefront of prostate cancer research and they have been recently evaluated as prognostic marker. p53 overexpression has been investigated independently in a large number of different malignancies for its potential value as prognostic marker (28) (29) . p53 is a tumour suppressor gene located in the chromosome 17p13.1. This gene has been described in more than half of human tumours and it endcodes for a protein with abnormal stability and long half-life detectable via immunohistochemistry using specific antibodies (30) . p53 mutation and expression are correlated with advanced disease, loss oftumour differentiation and the transition from androgen-dependent to androgen-independent growth (31) (32) (33) .
Since the mutation rate of the p53 gene in PCA is also low, researchers have speculated that an infectious agent might play a role in PCA (II). Polyomaviruses are candidates for this agent, although the etiological role of polyomaviruses in human tumors remains debatable despite several reports demonstrating the presence and expression of viral sequences in neoplastic cells (12) (13) (14) (15) .
Evidence supporting a possible role for BKV in human cancer has accumulated slowly in recent years. The advent of PCR technology allows investigators to examine even small biopsy samples for the presence of viral sequences. BKV DNA sequences have been reported in a wide range of human tumours, including those that do not represent the normal anatomical sites of the virus, such as rhabdomyosarcoma, lung, Kaposi's sarcoma, pancreas, liver, brain, and various urinary tract neoplasms (34) (35) (36) (37) . Interestingly, other reports found no evidence for BKV in brain tumors, urothelial carcinoma of the bladder and of the renal pelvis, medulloblastomas, meningiomas and ependymomas (38) (39) (40) . Therefore, there is no certain proof that human polyomavirus BK directly causes cancer in humans (20) . The presence of the BKV genome and, more importantly, the expression of its TAg early protein, could suggest that this virus may playa role in the development or progression of prostate cancer. The p53 tumor suppressor was first discovered as a cellular protein bound to large T antigen in SV40transformed cells (41) (42) .
Isaacs et al. demonstrated that transfer of the wild type p53 allele suppressed growth of human prostate cancer cells in colony-forming assays, suggesting a functional role of p53 protein in suppressing prostatic carcinogenesis (43) .
In this study, we confirm previous reports demonstrating the presence ofBKV DNA in prostate tumors and the expression of TAg in neoplastic lesions. Moreover, we analysed the presence of p53 gene mutations in the region of p53 encoding for DNA binding domains (exon 5 to 9). The results showed mutations in exons 6 (codon 213/CGAC GG), 8 and 9 (codon 273/CGT~CAT), whereas the exons 5 and 7 showed a wild type genotype. In light of these results, we hypothesize that BKV TAg might contribute to cellular transformation process triggered by p53 gene mutations in the region encoding for DNA binding site domains. These results might suggest that, in a subject heterozygote for p53 gene mutations, the poor quantity of wild type p53 protein could be sequestered from viral AgT promoting the development of a neoplastic phenotype. The interaction of TAg with p53 is widely reported in literature (12, 15, 20, (41) (42) (44) (45) (46) . In particular, Poulin et. al. (47) demonstrate that AgT is acetylated in vivo in a manner that depends on AgT's ability to bind to p53. TAg acetylation may provide a regulatory mechanism for T Ag binding to a cellular factor or playa role in another aspect of T Ag function.
Our present case report supports the hypothesis that BK virus could dysregulate cell metabolism conferring the infected cell properties' characteristic of neoplasia, discovering a new role for BKV as a possible important co-factor in pathogenesis and/or progression of PCA.
More investigations using a significative number of samples are needed to discover and study in greater details the possible role of BKV as a trigger of neoplastic transformation.
